{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:15:06Z","timestamp":1790021706746,"version":"4.0.1"},"reference-count":60,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The International Journal of Lower Extremity Wounds"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:p>In this review, unusual causes of leg ulcers are examined with an emphasis on pathophysiology, clinical presentation, and epidemiology. Cutaneous ulcers due to malignancy of unusual leg ulcers with hematologic disorders, vasculitis, sarcoidosis, calciphylaxis, Buerger\u2019s disease, and pyoderma gangrenosumare discussed.<\/jats:p>","DOI":"10.1177\/1534734603260250","type":"journal-article","created":{"date-parts":[[2004,4,21]],"date-time":"2004-04-21T20:41:30Z","timestamp":1082580090000},"page":"207-216","source":"Crossref","is-referenced-by-count":9,"title":["Leg Ulcers of Unusual Causes"],"prefix":"10.1177","volume":"2","author":[{"given":"Arun","family":"Chakrabarty","sequence":"first","affiliation":[{"name":"Solano Clinical Research, Davis, CA,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Phillips","sequence":"additional","affiliation":[{"name":"Boston University School of Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2003,12,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1996.tb122269.x"},{"key":"atypb2","unstructured":"2. Voisard JJ, Lazareth I, Baviera E, et al. Leg ulcers and cancer. 6 case reports. J Mal Vasc 2001;26: 85-91."},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"3. Granel F, Barbaud A, Schmutz JL. Basal and squamous cell carcinoma associated with chronic venous leg ulcers. Int J Dermatol 2000;40: 539-540.","DOI":"10.1046\/j.1365-4362.2001.01094.x"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02879.x"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.1998.7.3.121"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30651-X"},{"key":"atypb7","doi-asserted-by":"crossref","unstructured":"7. McCall CO, Chen SC. Squamous cell carcinoma of the legs in African Americans. J Am Acad Dermatol 2002;74: 524-529.","DOI":"10.1067\/mjd.2002.124083"},{"key":"atypb8","unstructured":"8. Bowman PH, Hogan DJ. Leg ulcers: a common problem with sometimes uncommon etiologies. Geriatrics 1999;54(3): 47-48."},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1989.01410010125024"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-0486(09)80013-6"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70172-X"},{"key":"atypb12","unstructured":"12. Boni R, Schuster C, Nehroff, et al. Epidemiology of skin cancer. Neuroendocrinol Lett 2002;23(suppl 2): 48-51."},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.4065\/72.4.356"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70221-Z"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526.31.3.191"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1042\/cs0980667"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526.30.4.277"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1999.tb01037.x"},{"key":"atypb19","unstructured":"19. Chaine B, Neonato MG, Girot R, et al. Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease. Arch Dermatol 2001;137: 467-470."},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-198202000-00023"},{"key":"atypb21","doi-asserted-by":"crossref","unstructured":"21. Buchner SA. Specific and nonspecific skin manifestations on leukemia. Schweiz Rundsch Med Prax 2002;91: 1071-1077.","DOI":"10.1024\/0369-8394.91.24.1071"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90232-5"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2001.00231.x"},{"key":"atypb24","unstructured":"24. Hachulla E, Rose C, Trillot N, et al. What vascular events suggest a myeloproliferative disorder? J Mal Vasc 2000;25: 382-387."},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1159\/000246434"},{"key":"atypb26","unstructured":"26. Kaufmann R, Landes E. Leg ulcers in essential thrombocythemia. Hautarzt 1984;35: 259-262."},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(74)90852-3"},{"key":"atypb28","unstructured":"28. Fitzpatrick TB, Johnson RA, Wolff K, editors. Color atlas and synopsis of clinical dermatology. 4th ed. New York: McGraw-Hill; 2001. p. 504-507."},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1997.tb03656.x"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04624.x"},{"key":"atypb31","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197103000-00001"},{"key":"atypb32","unstructured":"32. Nayak AK, Komatireddy G. Cardiac manifestations of the antiphospholipid antibody syndrome: a review. Mo Med 2002;99: 171-178."},{"key":"atypb33","unstructured":"33. Lin P, Phillips TJ. Systemic lupus erythematosus and antiphospholipid antibody syndrome. Wounds 2002;14: 221-225."},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.3109\/03009749609069986"},{"key":"atypb35","doi-asserted-by":"publisher","DOI":"10.7547\/87507315-92-6-350"},{"key":"atypb36","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2002.00033.x"},{"key":"atypb37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00171.x"},{"key":"atypb38","unstructured":"38. Vancheeswaran R, Azam A, Black C, et al. Localization of endothelin-1 and its binding sites in scleroderma skin. J Rheumatol 1994;21: 1268-1276."},{"key":"atypb39","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780331114"},{"key":"atypb40","unstructured":"40. Thurtle OA, Cawley MI. The frequency of leg ulceration in rheumatoid arthritis: a survey. J Rheumatol 1983;10: 507-509."},{"key":"atypb41","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04933.x"},{"key":"atypb42","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1990.tb126267.x"},{"key":"atypb43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.7.816"},{"key":"atypb44","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90100-X"},{"key":"atypb45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1998.tb00953.x"},{"key":"atypb46","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2002000600001"},{"key":"atypb47","unstructured":"47. Feldman D, Hochberg MC, Zizic TM, et al. Cutaneous vasculitis in adult polymyositis\/dermatomyositis. J Rheumatol 1983;10: 85-89."},{"key":"atypb48","unstructured":"48. Katta R. Cutaneous sarcoidosis: a dermatologic masquerader. Am Fam Physician 2002;65: 1581-1584."},{"key":"atypb49","unstructured":"49. Okamoto H. Cutaneous sarcoidosis. Nippon Rinsho 2002;60: 1801-1806."},{"key":"atypb50","unstructured":"50. Higashimoto I, Arata SI, Niena K. A case of acute sarcoidosis with polyarthralgia and erythema nodosum: Lofgren\u2019s syndrome. Nihon Kokyuki Gakkai Zasshi 2002;40: 679-682."},{"key":"atypb51","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890380087013"},{"key":"atypb52","unstructured":"52. Hafner J, Keusch G, Wahl C, et al. Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa 1998;27: 137-143."},{"key":"atypb53","doi-asserted-by":"crossref","unstructured":"53. Lin P, Goldberg L, Phillips TJ. Calciphylaxis. Wounds 2002; 14: 205-210.","DOI":"10.1023\/A:1019928411436"},{"key":"atypb54","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050008"},{"key":"atypb55","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X9700200109"},{"key":"atypb56","unstructured":"56. Stvrtinova V, Ambrozy E, Stvrtina S, et al. 90 years of Buerger\u2019s disease\u2014what has changed? Bratisl Lek Listy 1999;100: 123-128."},{"key":"atypb57","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(97)83697-1"},{"key":"atypb58","doi-asserted-by":"crossref","unstructured":"58. Czarbnacki M, Zdrojowy K, Adamiee R. Review of current etiopathogenetic data of Buerger\u2019s disease. Pol Merkuriusz Lek 2002; 13: 263-265.","DOI":"10.1023\/A:1021351703634"},{"key":"atypb59","doi-asserted-by":"crossref","unstructured":"59. Callen J. Management of pyoderma gangrenosum. Clin Exp Dermatol 2002;27: 328-337.","DOI":"10.1046\/j.1365-2230.2002.104319.x"},{"key":"atypb60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013383"}],"container-title":["The International Journal of Lower Extremity Wounds"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1534734603260250","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1534734603260250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:04:33Z","timestamp":1777457073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1534734603260250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1177\/1534734603260250"],"URL":"https:\/\/doi.org\/10.1177\/1534734603260250","relation":{},"ISSN":["1534-7346","1552-6941"],"issn-type":[{"value":"1534-7346","type":"print"},{"value":"1552-6941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}